The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JUNE 7, 2021

Filament Health partnered with TrPR Psychedelic Research Program at UCSF to advance drug candidates through clinical trials. a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development. Industry Developments.

Research and Development 98

Research and Development Clinical Trials Extraction Retail 98

Cannabis Law Report

JULY 24, 2021

At Mydecine, we are excited to expand our drug development program to include the improvement of entactogenic compounds,” said Rob Roscow, Chief Scientific Officer. “At At Mydecine, we are excited to expand our drug development program to include the improvement of entactogenic compounds,” said Rob Roscow, Chief Scientific Officer.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Project CBD

NOVEMBER 11, 2023

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Cannabis Law Report

AUGUST 9, 2021

Investors will continue to keep an eye on several ongoing clinical trials, as well as private companies that are gearing up to go public over the coming quarters. OTC: WUHN) recently announced that a research team funded by the company successfully published a third paper on the Dovepress platform. Industry Developments.

Clinical Trials 105

Clinical Trials Decriminalization Research and Development Treatment 105

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.

DEA 51

DEA Clinical Trials THC Research and Development 51

The Cannigma

DECEMBER 14, 2021

HHC was synthesized in Adams’ laboratory as part of research to understand the active compounds in the cannabis plant. The importance of this finding is that, similar to CBN, HHC may occur naturally as a degradation product in aged cannabis, extracts, and concentrates. Hexahydrocannabinol (HHC). What is hydrogenation?

Research and Development 116

Research and Development Clinical Trials Cannabinoids THC 116

Cannabis Law Report

JUNE 20, 2021

LeafCann ’s mission is to advance the re-introduction of plant-based extracts in medicine and nutrition through conducting and supporting product and industry research and development, clinical trials, commercial production, and GMP manufacturing.

Supply Chain 81

Supply Chain Clinical Trials Research and Development Medicine 81

Cannabis Law Report

SEPTEMBER 14, 2021

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

SpeedWeed

JULY 23, 2021

Denver is expanding Alzheimer’s research through the efforts of local company MedPharm. . The company plans to move forward with research efforts through a special Schedule I Researcher Licenses given specifically to the company by the Drug Enforcement Administration. Denver Company Moves Forward with Research License .

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

Cannabis Law Report

JULY 12, 2019

By: James Holley, Molecular Biologist, Scientific Officer, Mike Robinson, Co-founder, Research Institute, and Dr. David Ostrow, M.D., Research Director. International Cannabinoid Cancer Research Institute (Draft 5). This report (abstract below) asks if Epidiolex is as efficient a drug as the manufacturer believes it to be.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

MARCH 18, 2020

The company, a leader in hemp-derived CBD extract products, has created an internal research and development division led by a former healthcare executive to focus on the science of hemp-derived phytocannabinoids, terpenes and flavonoid compounds. Charlotte’s Web Holdings, Inc. Source: [link].

Clinical Trials 59

Clinical Trials Research and Development Terpenes Hemp 59

Veriheal

NOVEMBER 17, 2020

But this has failed in the past and could prevent measures from moving forward this time unless new research could be presented to sway the state medical board’s decision. ” One Ohio Physician Embraces Cannabis Research But Denies Effectiveness . Research Shows to be Supportive Despite it All.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

The Cannigma

JUNE 23, 2022

And while there is essentially no research to say what CBGA does when taken by humans, CBGA has undergone preliminary (preclinical) research for its effects in seizures, inflammation, diabetes, and even COVID infections. Pain and inflammation. More studies are needed to fully understand CBGA’s application in inflammation.

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

The Cannigma

DECEMBER 12, 2022

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

OCTOBER 15, 2021

(USOTC: PAOG) cited a British Medical Journal case study report published today on the effectiveness of CBD in the treatment of lung cancer and COPD as validation of PAOG’s ongoing research and development of its own respiratory disorder treatment under the name RespRx. 9,199,960).

Treatment 52

Treatment Research and Development CBD Clinical Trials 52

SpeedWeed

SEPTEMBER 4, 2021

The DEA published a new document in the Federal Register on September 2 requesting an increase in production for certain Schedule I and Schedule II substances so that it can initiate more research studies. . DEA firmly believes in supporting regulated research of schedule I controlled substances. View original article.

DEA 52

DEA Research and Development Clinical Trials Extraction 52

Cannabis Law Report

JULY 6, 2021

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.”

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

MMJ Recs

JULY 9, 2024

Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures. Clinical Evidence and Research Findings Research into the efficacy of medical marijuana for MS management has yielded promising results.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Cannabis Law Report

DECEMBER 23, 2021

Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment. Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment. However, regulations are constantly shifting.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

The Joint Blog

JANUARY 31, 2021

According to a new study published in the Journal of Medical Case Reports , the daily use of high-CBD (cannabidiol) marijuana extracts is associated with improvements in the behavioral symptoms related to autism spectrum disorder (ASD). The individual was given very low-doses of marijuana extracts, no larger than 0.2 ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

Cannabis Law Report

DECEMBER 20, 2021

Finally the definition of cannabis included ‘ flowering or fruiting tops (excluding seeds and leaves when not accompanied by tops ) from which resin is not extracted ‘ 4. The clinical trials shall be conducted to comply with Rule 158(B) of the Drugs and Cosmetics Rules. Recent Development.

Seed-To-Sale 52

Seed-To-Sale Hemp Food Clinical Trials 52

Cannabis Law Report

JANUARY 12, 2022

The sale will accelerate the development of Gb Sciences’ proprietary Parkinson’s disease and COVID-related Cytokine-Release Syndrome therapies. “We have emerged from this sale as a pure-play biopharmaceutical research and development company. LAS VEGAS, Jan. 11, 2022 (GLOBE NEWSWIRE) — Gb Sciences, Inc.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

MMJ Recs

JULY 11, 2024

It has shown effectiveness in helping individuals develop better sleep habits and manage insomnia symptoms without relying on medication. Image by Enecta Cannabis Extracts on Unsplash Medical Marijuana: An Overview What is Medical Marijuana? Another option available is the use of medical marijuana to address insomnia in patients.

Sleep 111

Sleep Treatment Research and Development Therapy 111

CannaMD

AUGUST 8, 2020

Researchers believe cannabis contains over 100 unique chemical compounds! government classified all cannabis varieties, including hemp, as Schedule I under the Controlled Substances Act (despite decades of agricultural research detailing its differences from marijuana). What makes CBD special? In 1970, the U.S. What can CBD do?

CBD 105

CBD DEA Research and Development Hemp 105

LifeCannMD

AUGUST 2, 2024

Cannabinoids have been shown to have anti-inflammatory effects, which may help reduce the inflammation that can contribute to migraines.Cannabis influences neurotransmitter release, helping to modulate the neural pathways involved in migraine development. More clinical trials are needed to establish definitive efficacy and safety profiles.

Clinical Trials 52

Clinical Trials Marijuana Research and Development Cannabinoids 52

Cannabis Law Report

JULY 14, 2021

(“ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. The research we completed is exploratory but the results are consistent with our earlier research. “The We look forward to the next chapters in their development”.

Research and Development 81

Research and Development Clinical Trials Events Treatment 81

Freedom Leaf

JANUARY 10, 2018

We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.

Research and Development 49

Research and Development Clinical Trials Strains Patients 49

Cannabis Law Report

JUNE 15, 2022

Materia is one of many other operators that have recently established a headquarters in Malta since the legislation permitting the production of medical cannabis products for research and medical purposes was enacted in 2018. Malta is an ideal testbed for research given its small size and business-friendly approach.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Packaging 52

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. For example, research shows that primary care physicians misdiagnosed 65.9% Mental Health Challenges. Psychedelics Provide a Solution.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Alchimia

JANUARY 25, 2022

While this research is certainly worth celebrating, the reality behind the message can be easily misunderstood in this age of social media. It seems that every time a positive clinical study relating to cannabis and COVID comes out, the world gets excited about the medical potential of weed as a miracle medicine to end the pandemic.

Research and Development 98

Research and Development Terpenes CBD Treatment 98

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. It covers the pipeline drug profiles, including clinical and nonclinical stage products. GWP42003-P: GW Research. Epilepsy Emerging Drugs Chapters.

Epilepsy 40

Epilepsy Clinical Trials Research and Development Pharmaceutical 40

Cannabis Law Report

SEPTEMBER 12, 2022

This yield gives us the capacity and scale we need to advance our analytical schedule while also developing our product pipeline,” he added. Optimi will also be using the mushrooms to further develop its on-site extraction methods and will use the product to finalize its naturally derived psilocybin offerings this fall.

History 52

History Clinical Trials Legalization Research and Development 52

Cannabis Law Report

NOVEMBER 29, 2019

Preliminary research has also shown that CBD has the potential to help patients with Parkinson’s and Alzheimer’s diseases. However, researchers have shown other potential health applications of cannabis and THC. For instance, the study showed a link between cannabis use and schizophrenia development. THC Oil Effects.

Oil 80

Oil THC Cannabinoids Research and Development 80